KYTHERA Biopharmaceuticals (KYTH) IPO Indicated to Open
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
The IPO for KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) is expected to open at 10:20AM ET after pricing 4,400,000 shares at $16, the top end of the expected $14-$16 range.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin Investment Trust (GBTC) Files to Offer Up to $500M in Stock in IPO; Plans to List on NYSE Arca
- Pluristem Therapeutics (PSTI) Increases Bought Deal Offering of Common Stock and Warrants to $15M
- Cesca Therapeutics (KOOL) Files to Offer Common Stock and Warrants
Create E-mail Alert Related CategoriesIPOs
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!